newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Reports Third Quarter 2025 Financial Results

--Commercially Launched ORLYNVAH™ in the United States in August 2025-- --Extended Cash Runway into Q2 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, Nov. 14, 2025